Cargando…
Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier
BACKGROUND: Prolongation of the QT interval on the electrocardiogram is clinically important due to the association with an increased risk of sudden cardiac death. A long QT interval may be genetically determined (congenital long QT syndrome) or be drug-induced long QT syndrome e.g. caused by pharma...
Autores principales: | Marstrand, Peter, Christensen, Alex Hørby, Bartels, Emil Daniel, Theilade, Juliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426086/ https://www.ncbi.nlm.nih.gov/pubmed/31020182 http://dx.doi.org/10.1093/ehjcr/yty106 |
Ejemplares similares
-
Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study
por: Marstrand, Peter, et al.
Publicado: (2021) -
KCNE1 D85N polymorphism — a sex-specific modifier in type 1 long QT syndrome?
por: Lahtinen, Annukka M, et al.
Publicado: (2011) -
Differential Association between HERG and KCNE1 or KCNE2
por: Um, Sung Yon, et al.
Publicado: (2007) -
The KCNE Tango – How KCNE1 Interacts with Kv7.1
por: Wrobel, Eva, et al.
Publicado: (2012) -
Differential Modulations of KCNQ1 by Auxiliary Proteins KCNE1 and KCNE2
por: Li, Pan, et al.
Publicado: (2014)